Sign In
Pharma
Dr Reddy's gets DCGI approval to conduct phase-3 trial of Sputnik V
Hyderabad based Dr Reddy's seeks approval from Health Canada for Favipiravir
Markets
Dr Reddy's ADRs listed on NSE IFSC
All eyes on Hyderabad, the vaccine hub
